These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 34436610)
1. Comparison of Midterm Outcomes Associated With Aspirin and Ticagrelor vs Aspirin Monotherapy After Coronary Artery Bypass Grafting for Acute Coronary Syndrome. Björklund E; Malm CJ; Nielsen SJ; Hansson EC; Tygesen H; Romlin BS; Martinsson A; Omerovic E; Pivodic A; Jeppsson A JAMA Netw Open; 2021 Aug; 4(8):e2122597. PubMed ID: 34436610 [TBL] [Abstract][Full Text] [Related]
2. Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies. Harris J; Pouwels KB; Johnson T; Sterne J; Pithara C; Mahadevan K; Reeves B; Benedetto U; Loke Y; Lasserson D; Doble B; Hopewell-Kelly N; Redwood S; Wordsworth S; Mumford A; Rogers C; Pufulete M Health Technol Assess; 2023 May; 27(8):1-257. PubMed ID: 37435838 [TBL] [Abstract][Full Text] [Related]
3. Safety of Preoperative Use of Ticagrelor With or Without Aspirin Compared With Aspirin Alone in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Grafting. Gherli R; Mariscalco G; Dalén M; Onorati F; Perrotti A; Chocron S; Verhoye JP; Gulbins H; Reichart D; Svenarud P; Faggian G; Santarpino G; Fischlein T; Maselli D; Dominici C; Musumeci F; Rubino AS; Mignosa C; De Feo M; Bancone C; Gatti G; Maschietto L; Santini F; Nicolini F; Gherli T; Zanobini M; Kinnunen EM; Ruggieri VG; Rosato S; Biancari F JAMA Cardiol; 2016 Nov; 1(8):921-928. PubMed ID: 27653165 [TBL] [Abstract][Full Text] [Related]
4. Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of randomised DACAB trial. Zhu Y; Zhang W; Dimagli A; Han L; Cheng Z; Mei J; Chen X; Wang X; Zhou Y; Xue Q; Hu J; Tang M; Wang R; Song Y; Kang L; Redfors B; Gaudino M; Zhao Q BMJ; 2024 Jun; 385():e075707. PubMed ID: 38862179 [TBL] [Abstract][Full Text] [Related]
5. Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study. Yan H; Tiemuerniyazi X; Song Y; Xu F; Feng W J Cardiothorac Surg; 2020 Jun; 15(1):155. PubMed ID: 32600365 [TBL] [Abstract][Full Text] [Related]
6. Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multicenter, randomized, controlled IVUS-ACS and ULTIMATE-DAPT trial. Ge Z; Gao XF; Kan J; Kong XQ; Zuo GF; Ye F; Tian NL; Lin S; Liu ZZ; Shao YB; He YQ; Wen SY; Yang Q; Xia Y; Wang ZZ; Xiao PX; Li F; Zeng HS; Yang S; Wang Y; Tao L; Gao DS; Qu H; Qian XS; Han YL; Chen F; Zhang JJ; Chen SL Am Heart J; 2021 Jun; 236():49-58. PubMed ID: 33621541 [TBL] [Abstract][Full Text] [Related]
7. Discontinuation of dual antiplatelet therapy and bleeding in intensive care in patients undergoing urgent coronary artery bypass grafting: a retrospective analysis. Vuilliomenet T; Gebhard C; Bizzozero C; Glauser S; Blum S; Buser A; Bolliger D; Grapow MTR; Siegemund M Interact Cardiovasc Thorac Surg; 2019 May; 28(5):665-673. PubMed ID: 30535154 [TBL] [Abstract][Full Text] [Related]
8. Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial. Vogel B; Baber U; Cohen DJ; Sartori S; Sharma SK; Angiolillo DJ; Farhan S; Goel R; Zhang Z; Briguori C; Collier T; Dangas G; Dudek D; Escaned J; Gil R; Han YL; Kaul U; Kornowski R; Krucoff MW; Kunadian V; Mehta SR; Moliterno D; Ohman EM; Sardella G; Witzenbichler B; Gibson CM; Pocock S; Huber K; Mehran R JAMA Cardiol; 2021 Sep; 6(9):1032-1041. PubMed ID: 33991416 [TBL] [Abstract][Full Text] [Related]
9. Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial. Schunkert H; Boening A; von Scheidt M; Lanig C; Gusmini F; de Waha A; Kuna C; Fach A; Grothusen C; Oberhoffer M; Knosalla C; Walther T; Danner BC; Misfeld M; Zeymer U; Wimmer-Greinecker G; Siepe M; Grubitzsch H; Joost A; Schaefer A; Conradi L; Cremer J; Hamm C; Lange R; Radke PW; Schulz R; Laufer G; Grieshaber P; Pader P; Attmann T; Schmoeckel M; Meyer A; Ziegelhöffer T; Hambrecht R; Kastrati A; Sandner SE Eur Heart J; 2019 Aug; 40(29):2432-2440. PubMed ID: 31145798 [TBL] [Abstract][Full Text] [Related]
10. Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor. Verdoia M; Nardin M; Gioscia R; Negro F; Marcolongo M; Suryapranata H; Kedhi E; De Luca G; Vascul Pharmacol; 2020 Sep; 132():106765. PubMed ID: 32681888 [TBL] [Abstract][Full Text] [Related]
11. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society. Fitchett D; Eikelboom J; Fremes S; Mazer D; Singh S; Bittira B; Brister S; Graham J; Gupta M; Karkouti K; Lee A; Love M; McArthur R; Peterson M; Verma S; Yau T Can J Cardiol; 2009 Dec; 25(12):683-9. PubMed ID: 19960127 [TBL] [Abstract][Full Text] [Related]
12. Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical Trial. Kim BK; Hong SJ; Cho YH; Yun KH; Kim YH; Suh Y; Cho JY; Her AY; Cho S; Jeon DW; Yoo SY; Cho DK; Hong BK; Kwon H; Ahn CM; Shin DH; Nam CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y; JAMA; 2020 Jun; 323(23):2407-2416. PubMed ID: 32543684 [TBL] [Abstract][Full Text] [Related]
13. Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Turgeon RD; Koshman SL; Youngson E; Har B; Wilton SB; James MT; Graham MM JAMA Intern Med; 2020 Mar; 180(3):420-428. PubMed ID: 31930361 [TBL] [Abstract][Full Text] [Related]
14. Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights. van Diepen S; Fuster V; Verma S; Hamza TH; Siami FS; Goodman SG; Farkouh ME J Am Coll Cardiol; 2017 Jan; 69(2):119-127. PubMed ID: 28081820 [TBL] [Abstract][Full Text] [Related]
15. Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. You SC; Rho Y; Bikdeli B; Kim J; Siapos A; Weaver J; Londhe A; Cho J; Park J; Schuemie M; Suchard MA; Madigan D; Hripcsak G; Gupta A; Reich CG; Ryan PB; Park RW; Krumholz HM JAMA; 2020 Oct; 324(16):1640-1650. PubMed ID: 33107944 [TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS). Kawashima H; Tomaniak M; Ono M; Wang R; Hara H; Gao C; Takahashi K; Sharif F; Thury A; Suryapranata H; Walsh S; Cotton J; Carrie D; Sabate M; Steinwender C; Leibundgut G; Wykrzykowska J; de Winter RJ; Garg S; Hamm C; Steg PG; Jüni P; Vranckx P; Valgimigli M; Windecker S; Onuma Y; Serruys PW Am J Cardiol; 2021 Jan; 138():1-10. PubMed ID: 33065080 [TBL] [Abstract][Full Text] [Related]
17. Randomized evaluation of ticagrelor monotherapy after 3-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with new-generation sirolimus-eluting stents: TICO trial rationale and design. Kim C; Hong SJ; Shin DH; Kim BK; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y Am Heart J; 2019 Jun; 212():45-52. PubMed ID: 30933857 [TBL] [Abstract][Full Text] [Related]
18. A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial. de Waha A; Sandner S; von Scheidt M; Boening A; Koch-Buettner K; Hammel D; Hambrecht R; Danner BC; Schöndube FA; Goerlach G; Fischlein T; Schmoeckel M; Oberhoffer M; Schulz R; Walther T; Ziegelhöffer T; Knosalla C; Schönrath F; Beyersdorf F; Siepe M; Attmann T; Misfeld M; Mohr FW; Sievers HH; Joost A; Putman LM; Laufer G; Hamm C; Zeymer U; Kastrati A; Radke PW; Lange R; Cremer J; Schunkert H Am Heart J; 2016 Sep; 179():69-76. PubMed ID: 27595681 [TBL] [Abstract][Full Text] [Related]
19. Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials. Verma S; Goodman SG; Mehta SR; Latter DA; Ruel M; Gupta M; Yanagawa B; Al-Omran M; Gupta N; Teoh H; Friedrich JO BMC Surg; 2015 Oct; 15():112. PubMed ID: 26467661 [TBL] [Abstract][Full Text] [Related]
20. Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry. De Filippo O; Cortese M; D Ascenzo F; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solé A; Manzano-Fernández S; Templin C; Velicki L; Xanthopoulou I; Cerrato E; Rognoni A; Boccuzzi G; Montefusco A; Montabone A; Taha S; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Blanco PF; Garay A; Quadri G; Varbella F; Queija BC; Paz RC; Fernández MC; Pousa IM; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Valdés M; Cequier A; Alexopoulos D; Iñiguez-Romo A; Rinaldi M Am J Cardiovasc Drugs; 2019 Aug; 19(4):381-391. PubMed ID: 31030413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]